McCollum Christoferson Group LLC Sells 240 Shares of The Clorox Company (NYSE:CLX)

McCollum Christoferson Group LLC trimmed its position in The Clorox Company (NYSE:CLX) by 3.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,285 shares of the company’s stock after selling 240 shares during the quarter. McCollum Christoferson Group LLC’s holdings in Clorox were worth $1,024,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CLX. Van ECK Associates Corp lifted its holdings in shares of Clorox by 1,715.5% during the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock worth $199,411,000 after acquiring an additional 1,380,724 shares during the period. Nuance Investments LLC boosted its holdings in Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after purchasing an additional 960,094 shares in the last quarter. Wulff Hansen & CO. grew its stake in shares of Clorox by 13,547.0% in the 2nd quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock valued at $60,063,000 after purchasing an additional 436,891 shares during the period. Acadian Asset Management LLC grew its stake in shares of Clorox by 26.5% in the 1st quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock valued at $135,099,000 after purchasing an additional 184,847 shares during the period. Finally, Los Angeles Capital Management LLC raised its holdings in shares of Clorox by 268.7% in the 1st quarter. Los Angeles Capital Management LLC now owns 192,982 shares of the company’s stock worth $29,547,000 after buying an additional 140,642 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Stock Up 0.1 %

NYSE CLX opened at $163.43 on Thursday. The stock has a market capitalization of $20.30 billion, a P/E ratio of 84.68, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The stock has a fifty day moving average of $158.53 and a 200-day moving average of $144.98.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The firm had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. On average, equities research analysts forecast that The Clorox Company will post 6.64 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 2.99%. Clorox’s dividend payout ratio is currently 252.85%.

Insider Buying and Selling at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.51% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. JPMorgan Chase & Co. upped their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. DA Davidson reaffirmed a “neutral” rating and issued a $153.00 target price on shares of Clorox in a report on Friday, September 6th. Wells Fargo & Company dropped their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and boosted their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Finally, Citigroup lifted their target price on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Six investment analysts have rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $150.14.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.